CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin
2021 · Cardio-Oncology · 13 citations
https://doi.org/10.1186/s40959-021-00103-0
J
Javier G. Blanco
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
122
Papers
2.7K
Citations
27
h-index
52
i10-index
Javier G. Blanco is an academic researcher from Biomedical Research Institute. The author has contributed to research in topics: Chemotherapy-induced cardiotoxicity and mitigation & Childhood Cancer Survivors' Quality of Life & Aldose Reductase and Taurine. The author has an h-index of 27, co-authored 104 publications.
ORCID: 0000-0003-3887-0370Papers by this author
worksHaptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors
2023 · JACC CardioOncology · 10 citations
https://doi.org/10.1016/j.jaccao.2022.09.009
Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy in Cancer Survivors
2023 · JACC CardioOncology · 9 citations
https://doi.org/10.1016/j.jaccao.2023.06.007
Analysis of the intracellular traffic of IgG in the context of Down syndrome (trisomy 21)
2021 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-021-90469-z
Impact of DYRK1A Expression on TNNT2 Splicing and Daunorubicin Toxicity in Human iPSC-Derived Cardiomyocytes
2022 · Cardiovascular Toxicology · 4 citations
https://doi.org/10.1007/s12012-022-09746-6
Analysis of Outpatient HER2 Testing in New York State Using the statewide Planning and Research Cooperative System
2018 · Pharmacogenomics · 2 citations
https://doi.org/10.2217/pgs-2018-0120
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat